Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063801

Chief Reg & Develop Officer gave up 446 shares (to pay taxes)

  • Chief Reg & Develop Officer acquired 1,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Powala Christopher Chief Reg & Develop Officer 2018-12-18 Option exercise +1,625 139,889 D
Powala Christopher Chief Reg & Develop Officer 2018-12-18 Shares withheld for taxes −446 $6.30 $2,810 139,443 D
Derivatives
Powala Christopher Chief Reg & Develop Officer 2018-12-18 Option exercise · Restricted Stock Units −1,625 1,625 D
Loading xslF345X03/doc4.xml…